Sam-A Pharm Balance Sheet Health
Financial Health criteria checks 5/6
Sam-A Pharm has a total shareholder equity of ₩214.0B and total debt of ₩4.5B, which brings its debt-to-equity ratio to 2.1%. Its total assets and total liabilities are ₩245.1B and ₩31.2B respectively. Sam-A Pharm's EBIT is ₩25.2B making its interest coverage ratio -5.7. It has cash and short-term investments of ₩73.0B.
Key information
2.1%
Debt to equity ratio
₩4.47b
Debt
| Interest coverage ratio | -5.7x |
| Cash | ₩72.97b |
| Equity | ₩213.98b |
| Total liabilities | ₩31.15b |
| Total assets | ₩245.14b |
Recent financial health updates
Recent updates
Should You Be Adding Sam-A Pharm (KOSDAQ:009300) To Your Watchlist Today?
Nov 13
Earnings Working Against Sam-A Pharm. Co., Ltd's (KOSDAQ:009300) Share Price Following 34% Dive
Aug 25Sam-A Pharm. Co., Ltd's (KOSDAQ:009300) Price Is Right But Growth Is Lacking After Shares Rocket 32%
Jul 11Should You Be Adding Sam-A Pharm (KOSDAQ:009300) To Your Watchlist Today?
Jun 21Sam-A Pharm. Co., Ltd's (KOSDAQ:009300) Shares Bounce 26% But Its Business Still Trails The Market
May 25Key Things To Consider Before Buying Sam-A Pharm. Co., Ltd (KOSDAQ:009300) For Its Dividend
Apr 08Is Sam-A Pharm (KOSDAQ:009300) A Risky Investment?
Mar 04How Much Did Sam-A Pharm's(KOSDAQ:009300) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 28
Four Days Left To Buy Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Before The Ex-Dividend Date
Dec 24Sam-A Pharm. Co., Ltd (KOSDAQ:009300) Is Yielding 1.6% - But Is It A Buy?
Dec 07Financial Position Analysis
Short Term Liabilities: A009300's short term assets (₩109.9B) exceed its short term liabilities (₩23.1B).
Long Term Liabilities: A009300's short term assets (₩109.9B) exceed its long term liabilities (₩8.0B).
Debt to Equity History and Analysis
Debt Level: A009300 has more cash than its total debt.
Reducing Debt: A009300's debt to equity ratio has increased from 1.3% to 2.1% over the past 5 years.
Debt Coverage: A009300's debt is well covered by operating cash flow (727.3%).
Interest Coverage: A009300 earns more interest than it pays, so coverage of interest payments is not a concern.